Cytostatic Agent – Mechanism, Uses and Side Effects

What Is a Cytostatic Agent?

A cytostatic agent (plural: cytostatics) is a pharmacological substance capable of inhibiting uncontrolled cell growth or selectively destroying cells. The term derives from the Greek words kytos (cell) and statikos (causing to stand, inhibiting). Cytostatic agents are the cornerstone of chemotherapy and are primarily used to treat malignant tumors (cancers).

Because cancer cells divide rapidly and uncontrollably, cytostatics preferentially target actively dividing cells. However, they do not act exclusively on cancer cells – they can also affect healthy, rapidly dividing cells such as those in the bone marrow, the gastrointestinal lining, and hair follicles. This explains many of the well-known side effects associated with chemotherapy.

Mechanism of Action

Cytostatic agents work through a variety of mechanisms that interfere with the cell cycle and cell division. They are classified into several groups based on their mode of action:

• Alkylating agents (e.g., cyclophosphamide): These substances form chemical cross-links within the DNA strands, preventing the cancer cell from reading or replicating its genetic material correctly.
• Antimetabolites (e.g., methotrexate, 5-fluorouracil): These mimic the natural building blocks of DNA or RNA, thereby disrupting their synthesis and blocking cell division.
• Topoisomerase inhibitors (e.g., irinotecan, etoposide): These block enzymes responsible for unwinding and repairing DNA, leading to DNA strand breaks and cell death.
• Mitotic inhibitors / spindle poisons (e.g., paclitaxel, vincristine): These interfere with the formation of the mitotic spindle that separates chromosomes during cell division, preventing successful mitosis.
• Anthracyclines (e.g., doxorubicin): These intercalate between DNA strands and inhibit enzymes critical to DNA replication and transcription.

Indications and Areas of Use

Cytostatic agents are used in the treatment of a wide range of cancers, including:

• Breast cancer (mammary carcinoma)
• Lung cancer (bronchial carcinoma)
• Colorectal cancer (colon carcinoma)
• Leukemias and lymphomas (blood cancers)
• Ovarian cancer (ovarian carcinoma)
• Gastric and other gastrointestinal tumors

Some cytostatic agents are also used in the treatment of autoimmune diseases such as rheumatoid arthritis or multiple sclerosis, due to their immunosuppressive properties.

Dosage and Administration

Cytostatic agents are typically administered according to a defined treatment protocol consisting of treatment cycles alternating with rest periods, allowing the body time to recover. Administration is most commonly intravenous (via infusion), but depending on the agent, it may also be oral (tablet or capsule) or intrathecal (into the spinal canal).

Dosage is calculated based on individual patient factors including body surface area, renal and hepatic function, and overall health status.

Side Effects

Because cytostatic agents affect all rapidly dividing cells – not only tumor cells – they can produce a range of side effects:

• Bone marrow suppression: Reduced blood cell production leading to anemia, increased susceptibility to infection, and a tendency to bleed.
• Nausea and vomiting: Common but largely manageable with modern antiemetic medications.
• Hair loss (alopecia): Occurs with many but not all cytostatic agents; generally reversible after treatment ends.
• Mucositis: Inflammation of the mucous membranes of the mouth and gastrointestinal tract.
• Fatigue: Profound exhaustion that may persist beyond the treatment period.
• Organ toxicity: Depending on the specific agent, the heart, kidneys, lungs, or nervous system may be affected.
• Increased risk of secondary cancers: Long-term use is associated with a slightly elevated risk of developing secondary malignancies.

Cytostatic Agents in Cancer Therapy

Cytostatic agents are rarely used in isolation. They are frequently combined with other treatment modalities to increase efficacy and reduce the risk of resistance:

• Radiation therapy (radiochemotherapy)
• Targeted therapies using monoclonal antibodies or tyrosine kinase inhibitors
• Immunotherapy (e.g., checkpoint inhibitors)
• Hormone therapy for hormone-sensitive tumors

Combining agents with different mechanisms of action increases the likelihood of treatment success and helps prevent the tumor cells from developing resistance.

Safety Considerations in Handling Cytostatic Agents

Cytostatic agents are classified as hazardous substances. Their preparation and administration must follow strict safety protocols to protect healthcare workers and the surrounding environment. In hospitals and pharmacies, cytostatics are prepared under sterile conditions in dedicated biological safety cabinets.

References

1. Brunton, L. L., Hilal-Dandan, R., Knollmann, B. C. (Eds.) (2018). Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 13th Edition. McGraw-Hill Education.
2. National Cancer Institute (NCI): Chemotherapy to Treat Cancer. Available at: https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
3. World Health Organization (WHO): Cancer – Chemotherapy. Available at: https://www.who.int/cancer